These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20298813)

  • 21. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
    Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
    J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of acute lung allograft rejection in rat by the janus kinase 3 inhibitor, tyrphostin AG490.
    Higuchi T; Shiraishi T; Shirakusa T; Hirayama S; Shibaguchi H; Kuroki M; Hiratuka M; Yamamoto S; Iwasaki A; Kuroki M
    J Heart Lung Transplant; 2005 Oct; 24(10):1557-64. PubMed ID: 16210130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
    Jordan JL; Hirsch GM; Lee TD
    Transpl Immunol; 2008 Jul; 19(3-4):159-66. PubMed ID: 18619544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immune tolerance induced by staphylococcal enterotoxin B for the treatment of rat high-risk corneal transplantation rejection].
    Jie Y; Pan ZQ; Chen Y; Zhang WH; Xu L; Wu YY; Peng H
    Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):150-5. PubMed ID: 15840343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts.
    Pascher A; Reutzel-Selke A; Jurisch A; Bachmann U; Heidenhain C; Nickel P; Reinke P; Brandt C; Pratschke J; Frei U; Neuhaus P; Volk HD; Tullius SG
    Transplantation; 2003 Dec; 76(11):1560-8. PubMed ID: 14702524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N; Aghdaie MH; Malekpour Z
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-1-induced tolerogenic dendritic cells combined with apoptotic lymphocytes prolong liver allograft survival.
    Peng Y; Ye Y; Jia J; He Y; Yang Z; Zhu X; Huang H; Wang W; Geng L; Yin S; Zhou L; Zheng S
    Int Immunopharmacol; 2018 Dec; 65():470-482. PubMed ID: 30390594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring tolerance and rejection in organ transplant recipients.
    Sawitzki B; Schlickeiser S; Reinke P; Volk HD
    Biomarkers; 2011 Jul; 16 Suppl 1():S42-50. PubMed ID: 21707443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor non-specific IFN-gamma production by primed alloreactive cells as a potential screening test to predict the alloimmune response.
    Bendjelloul F; Desin TS; Shoker AS
    Transpl Immunol; 2004 Jan; 12(2):167-76. PubMed ID: 14967315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation.
    Yuan R; El-Asady R; Liu K; Wang D; Drachenberg CB; Hadley GA
    J Immunol; 2005 Sep; 175(5):2868-79. PubMed ID: 16116173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of Galectin-1 accelerates CD8⁺ T cell-mediated graft rejection.
    Moreau A; Noble A; Ratnasothy K; Chai JG; Deltour L; Cuturi MC; Simpson E; Lechler R; Lombardi G
    Eur J Immunol; 2012 Nov; 42(11):2881-8. PubMed ID: 22865279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.